Evofem Biosciences stock reverses lower, falls 10.3% after being up as much as 40.2% earlier

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Evofem Biosciences Inc.

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women’s sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply